FluMist, a needle-free nasal spray flu vaccine, is now available for at-home administration. The first of its kind, FluMist allows caregivers aged 18 or older to administer the vaccine to individuals between the ages of 2 and 49. This convenient option aims to improve access and uptake of the flu vaccine.
FluMist, a nasal spray flu vaccine that you or a caregiver can now give at home — no health care provider needed. It's the first flu vaccine of its kind, offering a needle-free option that's both simple and convenient, and its maker hopes it will improve access and uptake.
FluMist contains a weakened, harmless version of the flu virus and needs to be taken once a year. The flu, as you probably know, can cause symptoms like a fever, stuffy nose, sore throat, coughing, body aches, and fatigue. It tends to make the rounds in the fall and winter, affecting millions each year. FluMist protects against two common flu virus types, A and B, and is suitable for anyone age 2 to 49.
Those interested in using FluMist at home will still need a prescription. But there's good news: An online pharmacy will soon offer the vaccine. AstraZenecathat after completing a screening process to confirm eligibility, patients will receive their prescription and have FluMist shipped directly to their door, along with detailed instructions on how to store and use it. FluMist will also continue to be available at doctors' offices and pharmacies.
For children between 2 and 17, the FDA recommends that a caregiver give the spray. Common side effects include a runny or stuffy nose, fever in younger children, and a sore throat in adults.WebMD Inc. This news article was written and produced by staff at WebMD Health and is intended for a consumer audience. Questions or comments? Email newstip@webmd.net.How the End of the COVID Public Health Emergency May Affect You
Flumist Nasal Spray Vaccine At-Home Use Flu Prevention Healthcare Access
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FluMist nasal spray becomes first self-administered influenza vaccineThe Food and Drug Administration (FDA) has broadened the approval of FluMist nasal spray, making it the first 'self-administered' influenza vaccine. While the change won't be available until next year's flu season, adults will soon be able to buy and administer the vaccine to themselves or their children at home with a prescription.
Read more »
FluMist Nasal Spray Becomes First Self-Administered Flu VaccineThe Food and Drug Administration (FDA) has approved AstraZeneca's FluMist nasal spray as the first 'self-administered' influenza vaccine. While this approval is significant, the change won't be available for home shipping until next year's flu season.
Read more »
FDA approves first nasal spray flu vaccine for use at homeConsumers with a prescription will be able to order FluMist online starting next year.
Read more »
At-home nasal spray flu vaccine to be available in fall of 2025The FDA Friday approved the flu vaccine that can be done at home and does not need to be administered by a health care provider.
Read more »
FDA Approves Nasal Spray Flu Vaccine You Can Give Yourself (or Your Kids) at HomeThe FDA has approved FluMist, a nasal spray flu vaccine, to be self-administered at home. Here's what to know.
Read more »
At-home nasal spray flu vaccine to be available in fall of 2025The FDA Friday approved the flu vaccine that can be done at home and does not need to be administered by a health care provider.
Read more »